Effect of ZP123, a gap junction modifier, on prolonged ventricular fibrillation in swine

Cardiology

Volumn 118, Issue 3, 2011, Pages 147-152

  Li, Jing Sha ^a   Zhong, Jing Quan ^a   Zeng, Qi Xian ^a   Liu, Hong Zhen ^a   Su, Guo Ying ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Defibrillation; Prolonged ventricular fibrillation; Return of spontaneous circulation; ZP123

Indexed keywords

ROTIGAPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCULATION; CONTROLLED STUDY; DEFIBRILLATION; DRUG EFFECT; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; LOADING DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SWINE; TREATMENT OUTCOME;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ELECTRIC COUNTERSHOCK; FEMALE; GAP JUNCTIONS; MALE; OLIGOPEPTIDES; SUS SCROFA; SWINE; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 79956205329     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000328016     Document Type: Article

References (23)

1. Dhein S, Tudyka T: Therapeutic potential of antiarrhythmic peptides. Cellular coupling as a new antiarrhythmic target. Drugs 1995; 49: 851-855.
2. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A: Amiodarone as com-pared with lidocaine for shock-resistant ven-tricular fibrillation. N Engl J Med 2002; 346: 884-890. (Pubitemid 34984636)
3. Dorian P, Fain ES, Davy JM, Winkle RA: Li-docaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. J Am Coll Cardiol 1986; 8:327-332. (Pubitemid 16036466)
4. Kudenchuk PJ, Cobb LA, Copass MK, Cum-mins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T: Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventric-ular fibrillation. N Engl J Med 1999; 341: 871-878. (Pubitemid 29427049)
5. Eloff BC, Gilat E, Wan X, Rosenbaum DS: Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for anti-arrhythmic therapy. Circulation 2003; 108: 3157-3163. (Pubitemid 38031807)
6. Xing D, Kjølbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou NH, Martins JB: ZP123 increases gap junctional conduc-tance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 2003; 14:510-520. (Pubitemid 36583913)
7. Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S: Model-dependent effects of the gap junction conduction-en-hancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation 2007; 115:310-318. (Pubitemid 46151658)
8. Lin X, Crye M, Veenstra RD: Regulation of connexin 43 gap junctional conductance by ventricular action potentials. Circ Res 2003; 93: 63-73.
9. ECC Committee, Subcommittees and Task Forces of the American Heart Association: 2005 American Heart Association Guide-lines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circu-lation 2005; 112:IV1-IV203.
10. Rittenberger JC, Suffoletto B, Salcido D, Logue E, Menegazzi JJ: Increasing CPR dura-tion prior to first defibrillation does not im-prove return of spontaneous circulation or survival in a swine model of prolonged ven-tricular fibrillation. Resuscitation 2008; 79: 155-160.
11. Povoas HP, Weil MH, Tang W, Bisera J, Klouche K, Barbatsis A: Predicting the suc-cess of defibrillation by electrocardiographic analysis. Resuscitation 2002; 53: 77-82. (Pubitemid 34310213)
12. Kjølbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS: Pharmacological character-ization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J Pharmacol Exp Ther 2003; 306:1191-1199.
13. Aonuma S, Kohama Y, Akai K, Komiyama Y, Nakajima S, Wakabayashi M, Makino T: Studies on heart. 19. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem Pharm Bull (Tokyo) 1980; 28:3332-3339. (Pubitemid 11169094)
14. Hennan JK, Swillo RE, Morgan GA, Keith JC Jr, Schaub RG, Smith RP, Feldman HS, Haugan K, Kantrowitz J, Wang PJ, Abu- Qare A, Butera J, Larsen BD, Crandall DL: Roti-gaptide (ZP123) prevents spontaneous ven-tricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion in-jury in open-chest dogs. J Pharmacol Exp Ther 2006; 317:236-243.
15. Kjølbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS: Pharmacological charac-terization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J Pharmacol Exp Ther 2003; 306:1191-1199. (Pubitemid 37028306)
16. Sims JJ, Schoff KL, Loeb JM, Wiegert NA: Regional gap junction inhibition increases defibrillation thresholds. Am J Physiol Heart Circ Physiol 2003; 285:H10-H16. (Pubitemid 36736409)
17. Peters NS, Coromillas J, Severs NJ, Wit AL: Disturbed connexin 43 gap junction distri-bution correlates with the location of re-en-trant circuits in the epicardial border zone of healing canine infarcts that cause ventricu-lar tachycardia. Circulation 1997; 95:988-996. (Pubitemid 27091545)
18. Liu HZ, Zhong JQ, Li JS, Su GY, Wang J, Zhang Y: Changes in myocardial connexin 43 during ventricular fibrillation. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010; 22: 595-598.
19. Berg RA, Hilwig RW, Karl B, Ewy GA: Pre-countershock cardiopulmonary resuscita-tion improves ventricular fibrillation medi-an frequency and myocardial readiness for successful defibrillation from prolonged ventricular fibrillation: a randomized, con-trolled swine study. Ann Emerg Med 2002; 40: 563-570. (Pubitemid 35417477)
20. Reynolds JC, Salcido DD, Menegazzi JJ: Cor-onary perfusion pressure and return of spon-taneous circulation after prolonged cardiac arrest. Prehosp Emerg Care 2010; 14:78-84.
21. Eftestol T, Wik L, Sunde K, Steen PA: Effects of cardiopulmonary resuscitation on predic-tors of ventricular fibrillation defibrillation success during out-of-hospital cardiac ar-rest. Circulation 2004; 110:10-15. (Pubitemid 38885701)
22. Weaver WD, Cobb LA, Dennis D, Ray R, Hallstrom AP, Copass MK: Amplitude of ventricular fibrillation waveform and out-come after cardiac arrest. Ann Intern Med 1985; 102: 53-55. (Pubitemid 15187655)
23. Zhong JQ, Laurent G, So PP, Hu X, Hennan JK, Dorian P: Effects of ZP123, a gap junction modifier, on defibrillation energy and resus-citation from cardiac arrest in rabbits. J Car-diovasc Pharmacol Ther 2007; 12:69-77. (Pubitemid 46668080)